Clinical Trial Update: Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the loratadine/montelukast combination for congestion in Seasonal Allergic Rhinitis patients exposed to pollen; the study P04822 has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Loratadine (Loratadine)
• Montelukast (Montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED